4.5 Article

Transplanted Human Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Support Liver Regeneration in Gunn Rats

期刊

STEM CELLS AND DEVELOPMENT
卷 27, 期 24, 页码 1702-1714

出版社

MARY ANN LIEBERT, INC
DOI: 10.1089/scd.2018.0010

关键词

ESC; iPSC; iMSC; stem cell transplantation; liver regeneration; fetal MSC

资金

  1. German Research Foundation (DFG) through the Collaborative Research Center SFB 974 (Communication and Systems Relevance during Liver Injury and Regeneration,'' Dusseldorf)
  2. Federal Ministry of Education and Research-BMBF [01GN1005]
  3. Medical Faculty, Heinrich-Heine-University, Dusseldorf
  4. BBSRC [LO21072/1]
  5. MRC [MR/K026682/1]
  6. BBSRC [BB/L021072/1] Funding Source: UKRI
  7. MRC [MR/K026682/1] Funding Source: UKRI

向作者/读者索取更多资源

Gunn rats bear a mutation within the uridine diphosphate glucuronosyltransferase-1a1 (Ugt1a1) gene resulting in high serum bilirubin levels as seen in Crigler-Najjar syndrome. In this study, the Gunn rat was used as an animal model for heritable liver dysfunction. Induced mesenchymal stem cells (iMSCs) derived from embryonic stem cells (H1) and induced pluripotent stem cells were transplanted into Gunn rats after partial hepatectomy. The iMSCs engrafted and survived in the liver for up to 2 months. The transplanted iMSCs differentiated into functional hepatocytes as evidenced by partially suppressed hyperbilirubinemia and expression of multiple human-specific hepatocyte markers such as albumin, hepatocyte nuclear factor 4 alpha, UGT1A1, cytokeratin 18, bile salt export pump, multidrug resistance protein 2, Na/taurocholate-cotransporting polypeptide, and alpha-fetoprotein. These findings imply that transplanted human iMSCs can contribute to liver regeneration in vivo and thus represent a promising tool for the treatment of inherited liver diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据